Trial Profile
A first-in-man clinical trial of Micropump sodium oxybate in healthy volunteers
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2021
Price :
$35
*
At a glance
- Drugs Sodium oxybate (Primary)
- Indications Narcolepsy
- Focus Adverse reactions; Pharmacokinetics
- 02 Mar 2021 According to an Avadel Pharmaceuticals media release, data from this trial has been published in Clinical Therapeutics.
- 22 Feb 2021 Results from Four crossover, single-dose studies published in the Clinical Therapeutics
- 01 May 2020 Results assessing relative bioavailability of investigational once-nightly sodium oxybate, FT218, 6 g, compared to commercially available twice-nightly sodium oxybate and the food effect of FT218, presented at the 72nd Annual Meeting of the American Academy of Neurology.